AI assistant
Beyond Air, Inc. — Director's Dealing 2023
Mar 28, 2023
35161_dirs_2023-03-28_6e284af7-8077-4f3e-a025-6329a3505221.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Beyond Air, Inc. (XAIR)
CIK: 0001641631
Period of Report: 2023-03-27
Reporting Person: Myers Jeff Lynn (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-27 | Common Stock | A | 50000 | — | Acquired | 50000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-27 | Stock Option (right to buy) | $6.14 | A | 50000 | Acquired | 2033-03-26 | Common Stock (50000) | Direct |
Footnotes
F1: Represents restricted stock units ("RSUs") granted on March 27, 2023 to acquire 50,000 shares of common stock of Beyond Air, Inc. (the "Issuer"). The RSUs will vest as to 20% of the shares of common stock underlying the RSUs on December 15, 2023, with the remainder vesting in equal annual installments on December 15 of each of the four ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer.
F2: The option will vest as to 25% of the shares of common stock underlying the option on March 27, 2024, with the remainder vesting in equal annual installments on March 27 of each of the three ensuing years thereafter until vested in full, in each case subject to the reporting person's continued service with the Issuer.